SGMT Sagimet Biosciences Inc.: institutional ownership and insider trading
132 funds reported holding $409M of Sagimet Biosciences Inc. in their latest 13F filings; in Q2 2026 funds net bought $294M, with 57 new positions and 23 funds selling out; over the last 12 months insiders bought $0 and sold $4.91M on the open market.
SGMT revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$14.0M, EPS -0.26
- Quarter ended Mar 31, 2026: revenue n/a, net income −$10.7M, EPS -0.33
- Quarter ended Dec 31, 2025: revenue n/a, net income −$9.57M, EPS -0.30
- Quarter ended Sep 30, 2025: revenue n/a, net income −$12.9M, EPS -0.40
Famous investors holding SGMT
- Izzy Englander (Millennium Management): $7.24M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $2.68M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $2.24M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $633K, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $171K, 0.0% of the portfolio
Largest institutional holders of SGMT
- BlackRock, Inc. (BLK) — $50.8M
- BALYASNY ASSET MANAGEMENT L.P. — $28.0M
- Woodline Partners LP — $23.2M
- SILVERARC CAPITAL MANAGEMENT, LLC — $22.6M
- VANGUARD CAPITAL MANAGEMENT LLC — $19.8M
- BVF INC/IL — $19.3M
- Caligan Partners LP — $19.3M
- Affinity Asset Advisors, LLC — $19.3M
- FEDERATED HERMES, INC. (FHI) — $16.1M
- GREAT POINT PARTNERS LLC — $15.7M
Recent SGMT insider trades
- Aug 14, 2026: Kemble George sold 350,987 shares ($3.59M)
- Aug 11, 2026: Kemble George sold 20,206 shares ($201K)
- Jul 20, 2026: Kemble George sold 18,844 shares ($141K)
- Jul 20, 2026: Rozek Elizabeth sold 10,545 shares ($81.8K)
5%+ owners
- BlackRock, Inc.: 7.8% (Schedule 13G, filed Jul 30, 2026)
- Commodore Capital LP: 7.6% (Schedule 13G, filed Oct 7, 2026)
- BALYASNY ASSET MANAGEMENT L.P.: 5.9% (Schedule 13G, filed Aug 14, 2026)
Who owns the most SGMT stock?
The largest institutional holders of Sagimet Biosciences Inc. in the latest 13F filings are BlackRock, Inc. (BLK) ($50.8M), BALYASNY ASSET MANAGEMENT L.P. ($28.0M), Woodline Partners LP ($23.2M).
Are insiders buying or selling SGMT?
Over the last 12 months insiders bought $0 and sold $4.91M of Sagimet Biosciences Inc. stock on the open market (SEC Form 4).
Which famous investors own SGMT?
Izzy Englander, Renaissance Technologies, Ken Griffin, Two Sigma, D. E. Shaw.
Which ETFs hold SGMT?
2 ETFs and mutual funds hold it among their top 100 positions, including FKAIX, BRUSX.